Additionally, the discovery of TFAP2A as a transcription activator of SNAI1 enhances our understanding of the complex molecular pathways involved in TNBC progression, emphasizing TFAP2A as a key regulator in this aggressive subtype of breast cancer. The gene discussed is SNAI1; the disease is breast carcinoma.